Symbol | Exchange | Currency |
|---|
PerkinElmer (PKI): Q1 Non-GAAP EPS of $3.72 beats by $0.65; GAAP EPS of $3.37 beats by $0.78.Revenue of $1.31B (+100.7% Y/Y) beats by $100M.For the second quarter of 2021, the...
Investing.com - PerkinElmer (NYSE:PKI) reported on Tuesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations. PerkinElmer announced...
PerkinElmer (NYSE:PKI) declares $0.07/share quarterly dividend, in line with previous.Forward yield 0.21%Payable Aug.
PerkinElmer (NYSE:PKI) shares soared 6.9% in the last trading session to close at $136.57. The move was backed by solid volume with far more shares changing hands than in a normal...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 321.29 | 322.92 | 318.80 | +1.27 | +0.40% | 7.67M | NASDAQ | |||
| 2,364.84 | 2,370.37 | 2,346.72 | +27.49 | +1.18% | 700.03K | NASDAQ | |||
| 16.57 | 17.01 | 15.05 | +2.42 | +17.10% | 49.31M | NASDAQ | |||
| 264.75 | 265.00 | 258.59 | +7.99 | +3.11% | 2.22M | NASDAQ | |||
| 20.18 | 20.75 | 20.14 | +0.09 | +0.45% | 27.25M | NYSE | |||
| 227.05 | 228.78 | 226.52 | +0.63 | +0.28% | 4.70M | NYSE | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 118.04 | 119.42 | 117.91 | +1.04 | +0.89% | 4.53M | NYSE | |||
| 160.63 | 162.00 | 157.71 | -0.38 | -0.24% | 982.22K | NYSE | |||
| 28.28 | 29.50 | 28.11 | +0.12 | +0.43% | 818.26K | NASDAQ | |||
| 7.69 | 7.83 | 7.66 | +0.10 | +1.32% | 8.24M | NYSE | |||
| 86.78 | 86.87 | 85.42 | +1.17 | +1.37% | 323.61K | NYSE | |||
| 16.38 | 16.50 | 15.85 | +0.45 | +2.82% | 3.53M | NYSE | |||
| 9.43 | 9.79 | 9.14 | +0.42 | +4.72% | 24.56M | NYSE | |||
| 1.175 | 1.205 | 1.13 | +0.0250 | +2.17% | 6.47M | NYSE |
PerkinElmer Inc. is a provider of products, services and solutions for the diagnostics, life sciences and applied markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. Its Discovery & Analytical Solutions segment serves the life sciences and applied markets. Through the Diagnostics Segment, it offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals. It provides early detection for genetic disorders from pregnancy to early childhood, and infectious disease testing for the diagnostics market. It offers its product under various brands, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BoBs, chemagic, FragilEase, Genoglyphix, GSP, PG-Seq, PG-Find, Protein Clear, ProteinEXact and QSight, Glutomatic, Honigs Regression, HyperDSC, Inframatic, LAMBDA, NexION, NEN, OneSource, Opera Phenix, Operetta CLS and OsteoSense.